ArticleOncotarget2015

Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes.

Jessamy C Tiffen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.